| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $9.3M | +69.2% |
| R&D Expense | $36.3M | -11.0% |
| SG&A Expense | $14.6M | -12.6% |
| Operating Income | -$41.5M | +20.4% |
| Interest Expense | $100K | -23.1% |
| Income Tax | $400K | — |
| Net Income | -$40.7M | +19.8% |
| EPS (Basic) | -$0.72 | +35.1% |
| EPS (Diluted) | -$0.72 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $22.5M | -53.7% |
| Accounts Receivable | $945K | -44.3% |
| Current Assets | $25.1M | -51.1% |
| Total Assets | $32.2M | -47.7% |
| Current Liabilities | $13.7M | -19.9% |
| Long-term Debt | $0 | -100.0% |
| Total Liabilities | $14.7M | -39.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$36.3M | +9.1% |
| Capital Expenditures | $66K | — |
| Investing Cash Flow | $32K | -99.9% |
| Financing Cash Flow | $10.2M | -13.6% |
| Free Cash Flow | -$36.4M | +8.9% |
| +35.1% |
| Stockholders' Equity |
| $17.5M |
| -52.8% |